## Core Concept
Respiratory distress syndrome (RDS) in preterm babies is primarily caused by a deficiency of **surfactant**, a complex mixture of lipids and proteins that reduces surface tension in the lungs, facilitating easier lung expansion during breathing. The key component of surfactant related to its function is **dipalmitoylphosphatidylcholine (DPPC)**, a type of phospholipid.

## Why the Correct Answer is Right
The correct answer, **Dipalmitoylphosphatidylcholine (DPPC)**, is a crucial phospholipid component of lung surfactant. In preterm babies, the immature lungs often lack sufficient amounts of surfactant, leading to increased surface tension within the alveoli, which in turn causes the lungs to collapse and makes breathing difficult. DPPC's specific structure allows it to effectively decrease surface tension at the air-liquid interface in the alveoli, thereby preventing lung collapse.

## Why Each Wrong Option is Incorrect
- **Option A:** While phosphatidylethanolamine is a phospholipid present in cell membranes, it is not the primary component of lung surfactant responsible for reducing surface tension.
- **Option B:** Phosphatidylinositol is another phospholipid found in cell membranes and has roles in cell signaling but is not the key lipid deficient in RDS.
- **Option D:** Phosphatidylserine, like other options, is a phospholipid present in cell membranes but is not specifically identified as a major component of lung surfactant.

## Clinical Pearl / High-Yield Fact
A critical clinical pearl is that **exogenous surfactant replacement therapy** is a standard treatment for preterm infants with RDS, significantly improving survival and reducing complications. This therapy often involves administering surfactant preparations rich in DPPC.

## Correct Answer Line
**Correct Answer: C. Dipalmitoylphosphatidylcholine (DPPC).**